Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · 18 Jan 2022 Conference abstract · 1 Sep 2015 Tissue-specific autoimmune disorders: Antibody-proteases as a generation of highly informative and unique biomarkers to monitor subclinical and clinical stages of demyelination in multiple sclerosis (MS)
exhibited specific proteolytic cleavage of MBP The activity of the Ab-proteases markedly differs between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales ... often in MS…
Conference abstract · 11 Sep 2017 Antibodies with functionality as unique biomarkers and targets in drug discovery and regenerative medicine
proteases) represents Abs endowed with a capacity to provide proteolytic effects. Ab-proteases were shown to occur at clinical courses and evidently correlate with the severity of the disease ... specific proteolytic…
Conference abstract · 31 Aug 2020 Antibodies with Functionality as a New Generation of Translational Tools designed to be programmed via translational resources to predict and to prevent Demyelination
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination
Conference abstract Antibody-proteases as a generation of novel biomarkers and highly informative molecular tools to predict and to prevent demyelination
specific proteolytic cleavage of the MBP molecule The activity of the MBP-targeted Ab-proteases markedly differs between: (i) MS patients and healthy controls; (ii) different clinical MS courses ... common protease that…
Conference abstract · 1 Nov 2018 Antibodies with functionality as a new generation of translational tools to monitor, to predict and to prevent demyelination
mice with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: MS patients and healthy controls; different clinical MS courses and; EDSS scales of demyelination ... attacked by…
Conference abstract · 18 Apr 2022 Antibodies (Abs) with Functionality (Ab-Proteases) as a New Generation of Translational Tools designed get Healthcare Model Re-Armed
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination
Editorial · 3 Jun 2018 Tissue Engineering 2017: Antibodies with functionality as unique biomarkers and targets in drug discovery and regenerative medicine_SergeySuchkov_Moscow Engineering Physical Institute (MEPhI), Russia
proteases) represents Abs endowed with a capacity to provide proteolytic effects. Ab-proteases were shown to occur at clinical courses and evidently correlate with the severity of the disease ... specific proteolytic…
Conference abstract · 3 Jul 2017 Antibody-proteases as a novel biomarker and a unique target to manage demyelination: A new way for drug design and drug discovery
proteases) represents Abs endowed with a capacity to provide proteolytic effects. Ab-proteases were shown to occur at clinical courses and evidently correlate with the severity of the disease ... specific proteolytic…
Conference abstract · 14 Sep 2017 Ab-proteases as unique biomarkers and biopredictors to monitor Chronic inflammation of autoimmune origin at subclinical and clinical stages
above-mentioned autoimmune disorders. Ab-proteases from MS, AIM and AIT patients exhibited specific proteolytic cleavage of MBP, CM and thyroid Ags (T3, T3, TPO), respectively The activity ... proteases markedly differs…
Conference abstract · 21 Dec 2020 Antibodies with Functionality as a New Generation of Translational Tools designed to secure Upgraded Biodesign and Bioengineering of the Future to come
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination…
Conference abstract · 7 Sep 2017 A novel biomarker-based tool to monitor multiple sclerosis evolution at clinical and sub-clinical stages: Antibody-proteases as a new generation of translational tools to monitor, to predict and to prevent demyelination
clinical practice, i.e., (i) to confirm a diagnosis of subclinical stage of the disease course and (ii) to select a mode for preventive treatment to quench the autoimmune inflammation ... best known ones. Abs against…
Conference abstract · 28 Nov 2016 Abzymes as highly informative and unique biomarkers of the newest generation to monitor chronic autoimmune disorders at subclinical and clinical stages to predict features of the course
mentioned auto-immune disorders. Ab-proteases from MS, AIM and AIT patients exhibited specific proteolytic cleavage of MBP, CM and thyroid Ags (T3, T3, TPO), respectively The activity ... different clini-cal courses, to…
Conference abstract Antibody-Proteases: Predictive and Preventive Tools
with different types of the clinical course and (iii) among MS patients with different scales of disability. Bursts of the Ab-associated proteolytic activity have been confirmed ... exacerbation to predict the latter…
Conference abstract Antibody-proteases as translational tools of the latest generation to minimize risks of chronification of autoimmune disorders and disabling rates of the patients
traditional clinical practice, i.e., to confirm a diagnosis of subclinical stage of the disease course and to select a mode for preventive treatment to quench the autoimmune inflammation. In this ... capable of…
Conference abstract · 1 Sep 2015 PPPM as a model of healthcare services to operate biomarkers of newer generations to monitor clinical and subclinical stages of chronic inflammatory conditions of autoimmune origin
targeted proteolytic activity (so-called, Ab-proteases). Screening for those biomarkers could become the next step to secure subclinical diagnosis of MS and to predict the clinical course. The information
Conference abstract · 3 Nov 2014 Antibodies with functionality as a new generation of translational tools to monitor, to predict and to prevent demyelination
specific proteolytic cleavage of MBP.The activity of Ab-proteases markedly differed: (i)betweenMS patients and healthy controls and (ii) inpatients with different types of MS course. Moreover, the activity demonstrated…
Conference abstract · 26 Oct 2015 Antibody-proteases as promising tools of novel generation to be translated into clinical practice for having multistep (subclinical and clinical) demyelination monitoring secured
daily practice. Abs against myelin basic protein/MBP endowing with targeted and highly specific proteolytic activity (Ab-proteases) are appearing to be of great value to monitor demyelination at either ... blood samples…
Conference abstract Antibodies with functionality as a new generation of unique tools designed to be programmed via translational and targeted biodesign-related resources to suit the standards of the next-step generation
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination…
Conference abstract · 20 May 2019 Antibodies with functionality as a new generation of translational tools designed to be programmed via translational resources to predict and to prevent De-myelination
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination…
Conference abstract · 7 Dec 2017 Antibodies with functionality as a new generation of translational tools to monitor, predict and prevent demyelination
with EAE exhibited specific proteolytic cleavage of MBP which, in turn, markedly differed between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales of demyelination…
Conference abstract · 2018 Abzymes as unique biomarkers and targets to monitor and manage chronic disorders and to serve tools for bioengineering of the next-step generation
above-mentioned autoimmune disorders. Ab-proteases from MS, AIM and AIT patients exhibited specific proteolytic cleavage of MBP, CM and thyroid Ags (T3, T3, TPO), respectively The activity ... proteases markedly differs…
Conference abstract Ab-proteases as unique biomarkers and biopredictors to monitor chronic inflammation of autoimmune origin at subclinical and clinical stages
mentioned auto-immune disorders. Ab-proteases from MS, AIM and AIT patients exhibited specific proteolytic cleavage of MBP, CM and thyroid Ags (T3, T3, TPO), respectively. The activity ... controls, and (ii) different…
Conference abstract · 8 Aug 2022 Antibodies (Abs) with functionality (Ab-Proteases) as a new generation of translationaltools designed get healthcare model re-armed
autoimmunity conditions. Anti- MBP autoAbs from MS patients and patients with AIM exhibited specific proteolytic cleavage of MBP and CM, respectively, which, in turn, markedly differed between ... patients and healthy…
Conference abstract · 15 Apr 2014 Antibody-proteases as novel biomarkers and highly informative molecular tools to predict and to prevent demyelination
exhibited specific proteolytic cleavage of MBP The activity of the Ab-proteases markedly differs between: (i) MS patients and healthy controls; (ii) different clinical MS courses; (iii) EDSS scales

